The Role of Nutrition in the Development and Management of Chronic Obstructive Pulmonary Disease

Allison Heefner; Tijana Simovic; Kasey Mize; Paula Rodriguez-Miguelez

doi:10.3390/nu16081136

The Role of Nutrition in the Development and Management of Chronic Obstructive Pulmonary Disease

Nutrients. 2024 Apr 11;16(8):1136. doi: 10.3390/nu16081136.

Authors

Allison Heefner^{1

2}, Tijana Simovic¹, Kasey Mize¹, Paula Rodriguez-Miguelez^{1

3}

Affiliations

¹ Department of Kinesiology and Health Sciences, Virginia Commonwealth University, Richmond, VA 23284, USA.
² School of Medicine, Virginia Commonwealth University, Richmond, VA 23284, USA.
³ Division of Pulmonary and Critical Care, Virginia Commonwealth University, Richmond, VA 23284, USA.

Abstract

Chronic obstructive pulmonary disease (COPD) is a prevalent lung condition associated with significant morbidity and mortality. The management of COPD classically involves pulmonary rehabilitation, bronchodilators, and corticosteroids. An aspect of COPD management that is currently lacking in the literature is nutritional management, despite the prevalence of inadequate nutritional status in patients with COPD. In addition, certain nutritional imbalances have been reported to increase the risk of COPD development. This review summarizes the current literature on the role diet and nutrients may play in the risk and management of COPD development.

Keywords: COPD; alcohol; diet; fiber; iron; nitrates; nutrition; polyphenols; vitamins.

Publication types

Review

MeSH terms

Diet
Humans
Malnutrition / therapy
Nutritional Status*
Pulmonary Disease, Chronic Obstructive* / therapy
Risk Factors

Grants and funding

A.H. is supported by the Virginia Commonwealth University School of Medicine Dean’s Summer Fellowship, under P.R.-M. mentorship. T.S. is supported by a Predoctoral Fellowship from the American Heart Association (23PRE1018396), under P.R.-M. mentorship. P.R.-M. is supported by a Career Development Award from the American Heart Association (18CDA34110323), by a Rapid Response Project Awarded via NIDA and FDA Center for Tobacco Products (U54DA036105), by the Clinical and Translational Science Awards Program from NIH to Virginia Commonwealth University (UL1TR002649), and by the Child Health Research Institute of Children’s Hospital of Richmond at Virginia Commonwealth University.